Premium
Functional characterization of ABCC8 variants of unknown significance based on bioinformatics predictions, splicing assays, and protein analyses: Benefits for the accurate diagnosis of congenital hyperinsulinism
Author(s) -
SaintMartin Cécile,
CauchoisLe Mière Marine,
Rex Emily,
Soukarieh Omar,
Arnoux JeanBaptiste,
Buratti Julien,
Bouvet Delphine,
Frébourg Thierry,
Gaildrat Pascaline,
Shyng ShowLing,
BellannéChantelot Christine,
Martins Alexandra
Publication year - 2021
Publication title -
human mutation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.981
H-Index - 162
eISSN - 1098-1004
pISSN - 1059-7794
DOI - 10.1002/humu.24164
Subject(s) - minigene , biology , rna splicing , alternative splicing , exon , genetics , exon skipping , intron , computational biology , bioinformatics , gene , rna
ABCC8 encodes the SUR1 subunit of the β‐cell ATP‐sensitive potassium channel whose loss of function causes congenital hyperinsulinism (CHI). Molecular diagnosis is critical for optimal management of CHI patients. Unfortunately, assessing the impact of ABCC8 variants on RNA splicing remains very challenging as this gene is poorly expressed in leukocytes. Here, we performed bioinformatics analysis and cell‐based minigene assays to assess the impact on splicing of 13 ABCC8 variants identified in 20 CHI patients. Next, channel properties of SUR1 proteins expected to originate from minigene‐detected in‐frame splicing defects were analyzed after ectopic expression in COSm6 cells. Out of the analyzed variants, seven induced out‐of‐frame splicing defects and were therefore classified as recessive pathogenic, whereas two led to skipping of in‐frame exons. Channel functional analysis of the latter demonstrated their pathogenicity. Interestingly, the common rs757110 SNP increased exon skipping in our system suggesting that it may act as a disease modifier factor. Our strategy allowed determining the pathogenicity of all selected ABCC8 variants, and CHI‐inheritance pattern for 16 out of the 20 patients. This study highlights the value of combining RNA and protein functional approaches in variant interpretation and reveals the minigene splicing assay as a new tool for CHI molecular diagnostics.